Till Milde

34PUBLICATIONS
301CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|May 05, 2026
Combined Inhibition of ATR and Ribonucleotide Reductase Induces Synergistic Antineoplastic Activity in Osteosarcoma Cells.

|Feb 09, 2026
A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification.

Sybren L N Maas, Yiheng Tang, Eric Stutheit-Zhao

|Sep 15, 2025
A spatial map of MAPK-activated immunosuppressive myeloid populations in pediatric low-grade glioma.

Augusto Faria Andrade, Romain Sigaud, Evan Puligandla

|Aug 13, 2025
Cerebrospinal fluid liquid biopsy guides differential diagnosis of relapsed medulloblastoma versus secondary glioma: A case report of a pediatric patient enrolled on a PDGFRA inhibitor trial.

Tom T Fischer, Kendra K Maass, Melanie Schoof

|Jun 23, 2025
Multi-omics dissection of MAPK-driven senescence unveils therapeutic vulnerabilities in KIAA1549::BRAF-fusion pediatric low-grade glioma models.

Romain Sigaud, Anja Stefanski, Florian Selt

Pageof 6

Frequent Collaborators

14 joint publications

Stefan M Pfister

12 joint publications

Cornelis M van Tilburg

12 joint publications

Felix Sahm

10 joint publications

David T W Jones